4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-021548
Chief Business Development Off sold 1,354 shares at an average $41.69 ($56,451)
- Chief Business Development Off acquired 1,354 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Business Development Off
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 1 in the form | +1,354 | $31.71 | $42,935 | 24,248 | D |
| 2021-03-15 | Sale : show line 2 in the form | −340 | $41.22 | $14,015 | 23,908 | D |
| 2021-03-15 | Sale : show line 3 in the form | −1,014 | $41.85 | $42,436 | 22,894 | D |
| Open-market sales · 1,354 sh · avg $41.69 · $56,451 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −1,354 | 47,396 | D |
Loading xslF345X03/doc4.xml…